CD8A and neoplasm: Both ERK inhibitors nullified the UA‐enhanced cytokine‐producing capacity and cytotoxic activity against EL4 tumor in vitro (Figure 2F,G; Figure S3E,F, Supporting Information), indicating that UA regulates CD8+ CTL function through the ERK pathway.